[1] DAVIS S M, BRODERICK J, HENNERICI M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage[J]. Neurology, 2006, 66(8): 1175-1181.
[2] ZHANG Y, REILLY KH, TONG W, et al. Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China[J]. Hypertension, 2008, 26(7): 1446-1452.
[3] ANDERSON C S, QURESHI A I. Implications of INTERACT2 and other clinical trials: blood pressure management in acute intracerebral hemorrhage[J]. Stroke, 2015, 46(1): 291-295.
[4] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国脑出血诊治指南(2014)[J]. 中华神经科杂志, 2015, 48(6): 435-444.
[5] ANDERSON C S, HUANG Y, WANG J G, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial
(INTERACT): a randomised pilot trial[J]. Lancet Neurol, 2008, 7(5): 391-399.
[6] MANNING L, HIRAKAWA Y, ARIMA H, et al. Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial[J]. Lancet Neurol, 2014, 13(4): 364-373.
[7] TANAKA E, KOGA M, KOBAYASHI J, et al. Blood pressure variability on antihypertensive therapy in acute intracerebral hemorrhage: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-intracerebral hemorrhage study[J]. Stroke, 2014, 45(8): 2275-2279.
[8] RÅDHOLM K, ARIMA H, LINDLEY R I, et al. Older age is a strong predictor for poor outcome in intracerebral haemorrhage: the INTERACT2 study[J]. Age Ageing, 2015, 44(3):
422-427.
[9] DELCOURT C, ZHANG S, ARIMA H, et al. Significance of Hematoma Shape and density in intracerebral hemorrhage: the intensive blood Pressure Reduction in acute intracerebral Hemorrhage Trial Study[J]. Stroke, 2016, 47(5): 1227-1232.
[10] 郑国庆, 黄培新. 356例高血压幕上脑出血患者28天预后的影响因素[J]. 温州医学院学报, 2006, 36(1): 10-15.
|